¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Interferon Alfa-2a Solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • buffer solution
    ¿ÏÃæ¾×
  • Burow¡¯s solution
    ºÎ·Î¿ë¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×
  • crystalloid solution
    °áÁ¤Áú¿ë¾×
  • culture solution
    ¹è¾ç¾×
  • cardioplegic solution
    ½ÉÀåÁ¤Áö¾×
  • disclosing solution
    1. Ä¡ÅÂÂø»ö¾× 2. ³ëÃâ¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×
  • hypotonic solution
    ÀúÀå¾×
  • heavy solution
    Áß¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • isotonic solution
    µîÀå¾×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • conjugate solution
    ¦¿ë¾×
  • crystalloid solution
    Á¤Áú¾×
  • culture solution
    ¹è¾ç¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • disclosing solution
    Ä¡ÅÂÂø»ö¾×
  • equimolecular solution
    µîºÐÀÚ¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • heavy solution
    Áß¾×
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×, ³ôÀº»ïÅõ¾Ð¿ë¾×
  • hypertonic salt solution
    °íÀå½Ä¿°¼ö
  • hypotonic solution
    ÀúÀå¾×, ³·Àº»ïÅõ¾Ð¿ë¾×
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Lockes solution
    ·ÎÅ©¾×(¡­äû).
  • Lugols solution
    ·ç°ñ¾× (±×¶÷¿°»ö¿ë ¸Å¿°Á¦)
  • Ringer s solution
    ¸µ°Å¾×.
  • Ringers solution
    ¸µ°Å¾×
  • Tyrodes solution
    Ƽ·Îµå¾×
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¾ç¾×(â©åÆäû)
  • aseptic solution
    ¹«±Õ¾×(¡­äû).
  • aseptic solution
    ¹«±Õ¾×(¡­¾×).
  • glycerin and potash solution
    ±Û¸®¼¼¸° Ä®·ý¾×.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • heavy solution
    Áß¾×(ñìäû).
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö(Φ߫ûùâ©áÈ).
  • hypochromatosis =nuclear solution
    (ÇÙ)¿°Áú°¨¾à(ú·æøòõÊõå°) ÇÙºØA , ÇǺλö¼ÒÄ§Âø°¨¼ÒÁõ(ù«Ý±ßäáÈ ó·Êõá´ñø).
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö(î¸íåãÝç¤â©).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • interferon-¥â (INF-¥â)
    º£Å¸ÀÎÅÍÆä·Ð
  • interferon-¥ã (INF-¥ã)
    °¨¸¶ÀÎÅÍÆä·Ð
  • alkaline solution
    ¾ËÄ®¸®¼º ¿ë¾×.
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¾ç¾×(â©åÆäû)
  • aseptic solution
    ¹«±Õ¾×(¡­äû).
  • aseptic solution
    ¹«±Õ¾×(¡­¾×).
  • balanced salt solution (BSS)
    ÆòÇü¿° ¿ë¾× BSS
  • balanced salt solution =BSS
    ÆòÇü½Ä¿°¾×(¡­ãÝç¤äû)
  • balanced salt solution(=BSS)
    ÆòÇü¿°¾×
  • bleaching solution
    Ç¥¹é¿ë¾×.
  • boric acid solution
    ºØ»ê¼ö(ÝÝß«â©).
  • bromine solution
    ºê·Ò¿ë¾×(¡­éÁäû).
  • buffer solution
    ¿ÏÃæ¾×(èÐõúäû)
  • buffering solution
    ¿ÏÃæ¾×.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • isoosmolar solution
    µîÀå¾×(Ôõíåäû)
  • isosmotic solution
    µî»ïÅõ¾×(Ôõß¶÷âäû)
  • isotonic solution
    µîÀå¾×(Ôõíåäû)
  • Knop's solution
    Å©³ô¿ë¾×(éÁäû)
  • Krebs-Ringer solution
    Å©·¾½º-¸µ°Å ¿ë¾×(éÁäû)
  • Locke's solution
    ·Ï ¿ë¾×(éÁäû)
  • Lugol's solution
    ·ç°ñ ¿ë¾×(éÁäû)
  • molar solution
    ¸ô ¿ë¾×(éÁäû)
  • osmolal solution
    ¿À½º¸ô¶ö ¿ë¾×(éÁäû)
  • osmolar solution
    ¿À½º¸ô¶ó¸£ ¿ë¾×(éÁäû)
  • percent solution
    ÆÛ¼¾Æ® ¿ë¾×(éÁäû)
  • saturated solution
    Æ÷È­ ¿ë¾×(øéûùéÁäû)
  • solution
    ¿ë¾×(éÁäû)
  • solution hybridization
    ¿ë¾×(éÁäû) Æ¢±âÇü¼º(û¡à÷)
  • standard solution
    Ç¥ÁØ¿ë¾×(øöñÞéÁäû)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
INF-¥ã Interferon-¥ã
FIF feedback inhibition factor; fibroblast interferon; forced inspiratory flow; formaldehyde-induced flu...
HFI hereditary fructose intolerance; human fibroblast interferon
HFIF human fibroblast interferon
HLBI human lymphoblastoid interferon
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GBR Glutatione-bicarbonate-Ringer solution
HBSS Hank's Balanced Salt Solution
HSS hypertonic saline solution
PBS I--phosphate buffer solution
PSS K(+)-physiological salt solution
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • firing solution
    °íÁ¤¾×, Á¤Âø¾×
  • Harlmann sodium lactate solution
    Á¥»ê ³ªÆ®·ý ¿ë¾×, Çϸ£Æ®¸¸ ¿ë¾×, À¯»ê ³ªÆ®·ý ¿ë¾×
  • Hawship's solution
    ¾ÆÀÌ¾ä ¿ë¾×
  • hydrogen peroxide solution
    °ú»êÈ­ ¼ö¼Ò¼ö
  • hyperbaric solution
    °íºñÁß¾×
    ±âÁؾ׺¸´Ù ´õ Å« ºñÁßÀ» °®´Â ¿ë¾×. ¿¹¸¦ µé¸é ô¼ö ¸¶ÃëÁ¦·Î ô¼ö¾×ÀÇ ºñÁߺ¸´Ù Å« ºñÁßÀ» °®´Â ¾×ÀÌ ÁÖ»çµÇ¸é ÁÖ»ç ºÎÀ§ ¾Æ·¡ÂÊÀ¸·Î µµ´ÞÇÏ¿© ÀÌ ºÎÀ§°¡ ¸¶ÃëµÈ´Ù.
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö
  • interstitial solid solution
    ħÀÔÇü °í¿ëü
    ¿ë¸Å ±Ý¼ÓÀÇ °áÁ¤°ÝÀÚ »çÀÌ¿¡ ¿ëÁú ¿øÀÚ°¡ µé¾î°£ ±¸Á¶ÀÇ °í¿ëü.
  • isotonic solution
    µîÀ强 ¿ë¾×, µîÀå¾×
  • lactated Ringer's solution
    À¯»êÀ» °¡ÇÑ ¸µ°Å ¾×
  • Naegeli's solution
    ³×°Ö¸® ¿ë¾×
    È¿¸ð, °õÆÎÀÌ µî¿¡ »ç¿ëÇÏ´Â Àΰø ¹èÁö·Î, ÀÌ¿°±â¼º Àλê Ä®·ý 0.2g, ¿°È­ Ä®½· 0.1g, ÁÖ¼®»ê ¾Ï¸ð´½ 10gÀ» ¹° 1,000cc¿¡ ³ìÀÎ °Í.
  • normal saline solution
    Á¤¼º »ý¸® ½Ä¿°¼ö
  • novocaine solution
    ³ëº¸ÄÉÀÎ ¿ë¾×
  • ophthalmic solution
    ¾È°ú¿ë ¾×Á¦
  • parenteral solution
    ÁÖ»ç¾×
  • povidone-iodine solution

    powder (ºÐ¸», »êÁ¦

    °íÇüÀÇ ¾à¹°À» °¥°Å³ª ºÎ½¤ ¾òÀº ¼Ò¸³ÀÚÀÇ ÁýÇÕü.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
type II interferon <chemical> The major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon (interferon type I) and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease.
Pharmacological action: antineoplastic agent, antiviral agents.
Chemical name: Interferon-gamma (human lymphocyte protein moiety reduced)
(12 Dec 1998)
type I interferon <chemical> Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (interferon-alpha and interferon-beta).
Pharmacological action: antineoplastic agent, antiviral agents.
(12 Dec 1998)
fibroblast interferon <cytokine> One of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA. It is a cytokine with antiviral, antiproliferative, and immunomodulating activity.
Synonym: fibroblast interferon.
Pharmacological action: adjuvants, immunologic, antineoplastic agent, antiviral agents.
Chemical name: Interferon-alphaB (human leukocyte protein moiety reduced)
(12 Dec 1998)
leukocyte interferon <cytokine> One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells when exposed to live or inactivated virus, double-stranded RNA, or bacterial products.
It is the major interferon produced by virus-induced leukocyte cultures and, in addition to its pronounced antiviral activity, causes activation of NK cells. It is used experimentally in the treatment of hairy-cell leukaemia.
A number of different subtypes exist that are elaborated by leukocytes in response to viral infection or stimulation with double-stranded RNA; IFN-alpha-2A and -2B are protein products made by recombinant DNA techniques and are used as antineoplastic agents.
See: interferon-alpha 2a, interferon-alpha 2b
Synonym: leukocyte interferon.
Pharmacological action: antineoplastic agent, antiviral agent.
(20 Sep 2002)
acetic solution A vinegar.
(05 Mar 2000)
amaranth solution A 1% solution of amaranth (trisodium naphthol sulfonic acid), a synthetic vivid red dye, stable in acid and intensified in sodium hydroxide solution; used as a red or pink colourant in liquid pharmaceuticals.
(05 Mar 2000)
aqueous solution <chemistry> A solution in which water is the dissolving medium or solvent.
(09 Jan 1998)
barium solution A liquid containing barium sulfate, which shows up on X-rays. It outlines organs of the body so they can be seen on X-ray film.
(12 Dec 1998)
Benedict's solution <chemistry> An aqueous solution of sodium citrate, sodium carbonate, and copper sulfate which changes from its normal blue colour to orange, red, or yellow in the presence of a reducing sugar such as glucose.
See: Benedict's test for glucose.
(14 Aug 2000)
Burow's solution A preparation of aluminium subacetate and glacial acetic acid, used for its antiseptic and astringent action on the skin.
(05 Mar 2000)
Gallego's differentiating solution A dilute solution of formaldehyde and acetic acid used in a modified Gram stain to differentiate and enhance the basic fuchsin binding to Gram-negative microorganisms.
(05 Mar 2000)
Gey's solution A salt solution usually used in combination with naturally occurring body substances (e.g., blood serum, tissue extracts) and/or more complex chemically defined nutritive solution's for culturing animal cells.
(05 Mar 2000)
glucose solution, hypertonic Solution that is usually 10 percent glucose but may be higher. An isotonic solution of glucose is 5 percent.
(12 Dec 1998)
volumetric solution A solution made by mixing measured volumes of the components.
(05 Mar 2000)
chemical solution See: solution.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á